UK Transport minister: Vaccine might not work against S.African variant

The world’s leading COVID-19 vaccine makers are rushing to see if their shots work against new mutations of the novel coronavirus found in South Africa and the United Kingdom.

Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in the UK and South Africa, according to a laboratory study conducted by the U.S. drugmaker.

“The South African variant is worrying the experts because it may be that the vaccine doesn’t respond in the same way or doesn’t work in quite the same way,” Shapps told LBC radio. “This South African variant – this is a very big concern for the scientists.”

The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.

The mutation could be responsible for greater transmissibility and there had been concern it could also make the virus escape antibody neutralization elicited by the vaccine, said Phil Dormitzer, one of Pfizer’s top viral vaccine scientists.

Meanwhile Germany is considering suspending flights from more countries, including Ireland, over concerns of a more transmissible COVID-19 variant, German broadcaster n-tv reported on Friday, citing government sources.

The cabinet of Chancellor Angela Merkel could discuss rules similar to those that are in place for Britain at a meeting next week, the report said. The rules would come into effect immediately.

REUTERS